Senior Director, Analytical Development
Vertex Pharmaceuticals
Norwell, Massachusetts
Landon Greene, Ph.D., is currently serving as Senior Director Analytical Development at Vertex Pharmaceuticals. His group supports analytical CMC activities for clinical drug development, for serious and rare diseases, covering multiple drug modalities. Previously, he has worked for over 20 years at Esperion Therapeutics, Catalent Pharma Solutions, Bristol-Myers Squibb and Pfizer in various roles, primarily Analytical, supporting CMC activities in pre-clinical through commercial phases. Landon earned a B.S. in Chemistry / B.S.E in Chemical Engineering from the University of Michigan and a Ph.D. in Biochemistry from Rutgers University. As a volunteer, Landon previously served on the Eastern Analytical Symposium Executive Committee and the North Jersey Chromatography Group Organizing Committee for over 10 years. Additionally, he has served as the Chair of both the North Jersey Chromatography Group and the ACS North Jersey Local Section. Currently, Landon is serving on the Scientific Programming Committee for the AAPS Summer Scientific Forum.
Disclosure information not submitted.
Challenges in Analytical Method Validations and Transfers
Wednesday, July 24, 2024
1:30 PM – 3:10 PM CST